GRAS- and non-novel food-approved EPAX® Evolve 05 will debut at Vitafoods Europe Epax has launched EPAX® Evolve 05 – the world’s first commercially available VLC-PUFA (very long chain polyunsaturated fatty acid) product. VLC-PUFAs are a family of Omega-3 fatty acids that offer particular potential in the healthy ageing category. Pre-clinical studies have found that supplementation is associated with improved sight,1 and that depletion is linked to age-related phenomena such as reduced … [Read more...] about Epax launches first commercially available VLC-PUFA product
Epax
Epax boosts innovation and sustainability drive with $10 million investment
Epax is investing in a major upgrade to its main production facility, supporting both its drive to develop next-generation marine oil products and its commitment to sustainability. The $10 million investment in the facility in Aalesund, Norway, includes the construction of a new synthesis plant. It will use tailor-made Epax fractionation technology to gently modify fish oil and extract different fatty acids for bespoke nutrition products. Developed by Epax’s R&D team, the unique new … [Read more...] about Epax boosts innovation and sustainability drive with $10 million investment
Study indicates benefits of EPAX 4020TGN for muscle function and recovery
EPAX 4020TGN can help improve muscle contractile function and post-injury muscle recovery, a pilot study has found. The pre-clinical in vivo and in vitro research indicates that Epax’s highly concentrated, marine-derived triglyceride oil offers potential benefits for healthy aging and sports recovery. Researchers at the University of South Florida carried out an eight-week dietary intervention on adult and aging rats.* They were assigned either a control diet or one containing EPAX … [Read more...] about Study indicates benefits of EPAX 4020TGN for muscle function and recovery
